Your browser doesn't support javascript.
loading
Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial.
Kudriavtsev, Aleksandr V; Vakhrusheva, Anna V; Kryuchkov, Nickolay A; Frolova, Maria E; Blagodatskikh, Konstantin A; Ivanishin, Taras V; Djonovic, Milana; Romanovskaya-Romanko, Ekaterina A; Kovalenko, Anton N; Lioznov, Dmitry A; Zubkova, Tatiana G; Teplykh, Svetlana V; Oseshnyuk, Rodion A; Stukova, Marina A; Isaev, Artur A; Krasilnikov, Igor V.
Afiliação
  • Kudriavtsev AV; Betuvax LLC, 121096 Moscow, Russia.
  • Vakhrusheva AV; Betuvax LLC, 121096 Moscow, Russia.
  • Kryuchkov NA; Clinical Excellence Group LLC, 127051 Moscow, Russia.
  • Frolova ME; PJSC Human Stem Cells Institute, 129110 Moscow, Russia.
  • Blagodatskikh KA; Center of Genetics and Reproductive Medicine "Genetico", 119333 Moscow, Russia.
  • Ivanishin TV; Betuvax LLC, 121096 Moscow, Russia.
  • Djonovic M; PJSC Human Stem Cells Institute, 129110 Moscow, Russia.
  • Romanovskaya-Romanko EA; PJSC Human Stem Cells Institute, 129110 Moscow, Russia.
  • Kovalenko AN; Department of Vaccinology, Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197376 Saint Petersburg, Russia.
  • Lioznov DA; Clinical Excellence Group LLC, 127051 Moscow, Russia.
  • Zubkova TG; Department of Vaccinology, Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197376 Saint Petersburg, Russia.
  • Teplykh SV; Department of Vaccinology, Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197376 Saint Petersburg, Russia.
  • Oseshnyuk RA; Professor Clinic LLC, 614070 Perm, Russia.
  • Stukova MA; Ecosafety Center LLC, 195000 Saint Petersburg, Russia.
  • Isaev AA; Department of Vaccinology, Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197376 Saint Petersburg, Russia.
  • Krasilnikov IV; PJSC Human Stem Cells Institute, 129110 Moscow, Russia.
Vaccines (Basel) ; 11(2)2023 Feb 01.
Article em En | MEDLINE | ID: mdl-36851204
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article